Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# Nusano

## Sitemaps
[XML Sitemap](https://nusano.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [Nusano Completes Major Milestone Toward Commercial Radioisotope Production](https://nusano.com/beam-on-target-milestone/): Known internally as “Beam on Target,” the accomplishment is the first of three milestones en route to bringing the company’s radioisotope production platform online by the end of 2026.
- [BioSpace Previews Nusano Production Facility](https://nusano.com/biospace-nusano-production-facility-preview/): In April 2026, BioSpace senior editor Annalee Armstrong visited Nusano’s 190,000-square-foot production facility in West Valley City, Utah for an inside look at the company’s linear accelerator-based production platform.
- [Utah’s Expanded Right to Try Law: A Signal for Radiopharmaceutical Innovation](https://nusano.com/utahs-expanded-right-to-try-law-utah-right-to-try/): Published May 28, 2026
- [Nicole Vazquez Named to Utah Business Women to Watch List](https://nusano.com/nusanos-nicole-vazquez-utah-business-women-to-watch-list/): WEST VALLEY CITY, Utah – May 8, 2026 – Nusano's director of Logistics & Customer Service, Nicole Vazquez, has been named to Utah Business' 2026 "Women to Watch" List. The honor recognizes women making a  meaningful impact where they work and "trailblazing new paths in their fields."
- [May 30 – June 2, 2026 – SNMMI Annual Meeting](https://nusano.com/nusano-snmmi-2026/): WHAT: SNMMI 2026
- [April 30, 2026 – Nusano at Argonne Accelerator Institute](https://nusano.com/nusano-at-argonne-accelerator-institute/): On Thursday, April 30, 2026, Nusano's senior director of research and development, Elvin Harms, will present an overview of the Nusano radioisotope production platform at Argonne National Laboratory.
- [March 27, 2026 – BioHive Student Event @ Nusano](https://nusano.com/march-27-2026-biohive-student-event-nusano/): Individuals interested in attending should contact their local BioHive student chapter for full details.
- [March 12, 2026 – Wilson Sonsini Entrepreneur and Investor Life Sciences Summit](https://nusano.com/march-12-2026-wilson-sonsini-entrepreneur-and-investor-life-sciences-summit/): Nusano is exhibiting at the 2026 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit in downtown Salt Lake City. Stop by to meet the team and learn more about Nusano's work to make medical radioisotopes available and abundant.
- [Feb. 9, 2026 – BioUtah Life Sciences Day on Capitol Hill](https://nusano.com/bioutah-life-sciences-day-on-capitol-hill/): Life Sciences Day on Capitol Hill, organized by BioUtah
- [Talk Radioisotopes: 2025 Top Podcasts #1](https://nusano.com/talk-radioisotopes-2025-top-podcasts-1/): The Talk Radioisotopes podcast debuted in January 2025. To mark the end of the 2025 calendar year, we're counting down the top three most listened/downloaded episodes of the show. At #1 is Atley Solutions' Milton Lönnroth.
- [Talk Radioisotopes: 2025 Top Podcasts #2](https://nusano.com/talk-radioisotopes-2025-top-podcasts-2/): The Talk Radioisotopes podcast debuted in January 2025. To mark the end of the 2025 calendar year, we're counting down the top three most listened/downloaded episodes of the show. Coming in at #2 is Oppenheimer's Jeff Jones.
- [Talk Radioisotopes: 2025 Top Podcasts #3](https://nusano.com/talk-radioisotopes-2025-top-podcasts-3/): The Talk Radioisotopes podcast debuted in January 2025. To mark the end of the 2025 calendar year, we're counting down the top three most listened/downloaded episodes of the show. Coming in at #3 is Clarity Pharmaceuticals' Sheamus Gleason.
- [2025 Recap: A Look Back at How We Are Moving Forward](https://nusano.com/2025-a-look-back-at-how-we-are-moving-forward/): Shakespeare said the past is prologue. In that spirit, we submit this look back at 2025. It's been a year of tremendous progress at Nusano. Our teams are working to enable fields ranging from healthcare to nuclear energy. Every step of the way, we are guided by our core commitments of transforming possibilities into reality and to solving some of the world’s most pressing challenges. Our achievements in 2025 would not have been possible without the support of our many collaborators and friends. A heartfelt thanks to everyone who joined and followed our journey. Your support gives us strong momentum going into the new year. Enjoy this look back at 2025, while we charge forward. See you in '26!
- [Nusano Receives “Best Companies to Work For” Award from Utah Business](https://nusano.com/nusano-receives-best-companies-to-work-for-award-from-utah-business/): WEST VALLEY CITY, Utah – Dec. 11, 2025 – Nusano, physics company working to transform radioisotope production and enable industries ranging from healthcare to nuclear energy, today received a Best Companies to Work For award from Utah Business.
- [Anson Signs Non-Binding MOU Lithium Chloride Offtake Agreement with Nusano](https://nusano.com/anson-signs-non-binding-mou-lithium-chloride-offtake-agreement-with-nusano/): Dec. 8, 2025 – The following is a copy of an ASX announcement issued by Anson Resources. The original annoucement can be viewed on Anson's website. 
- [Nusano CEO Chris Lowe Joins BioUtah Board](https://nusano.com/nusano-ceo-chris-lowe-joins-bioutah-board/): BioUtah thanks Jay Muse and Michael Olson for eight years of dedicated service as members of the BioUtah Board and Myles Greenberg for three years of service on the executive committee. BioUtah is presently governed by a board of 16 directors representing the breadth and depth of Utah’s life sciences industry.
- [Quantum and Nusano Collaborate to Advance North American Critical Mineral Refining](https://nusano.com/quantum-and-nusano-collaborate-to-advance-north-american-critical-mineral-refining/): VANCOUVER, B.C., Canada and WEST VALLEY CITY, Utah, U.S.A. – Nov. 24, 2025 – Quantum Critical Metals Corp., (TSX.V: LEAP) (OTCQB: ATOXF) (FSE: 86A1) (“Quantum”) and Nusano, a physics-based technology company specializing in advanced mass-separation processes, have signed a memorandum of understanding to collaborate on the development and refining of critical minerals in North America. The partnership aims to strengthen supply chains for U.S. and Canadian industries by bringing high-purity mineral processing back to North American soil.
- [Nusano Receives Innovation Impact Award from BioUtah](https://nusano.com/nusano-receives-innovation-impact-award-from-bioutah/): SALT LAKE CITY – Nov. 12, 2025 – Nusano, a physics company enabling industries ranging from healthcare to nuclear energy, today accepted the 2025 Innovation Impact Award from BioUtah at the Utah Life Sciences Summit. The award honors organizations advancing life science innovations and creating transformative technologies.
- [A Declaration of Critical Minerals Independence](https://nusano.com/a-declaration-of-critical-minerals-independence/): To control our own destiny, the United States needs nothing short of a Declaration of Critical Minerals Independence. Government, private industry and communities must work together to accelerate innovation and reclaim leadership in the global mineral race. This should include significant investments in advanced extraction and refining technologies, increased minerals research and development, and domestic infrastructure investments.
- [Chris Lowe on Healthcare Technology Report Podcast](https://nusano.com/chris-lowe-on-healthcare-technology-report-podcast/): Nov. 6, 2025 – Nusano CEO, Chris Lowe, is the featured guest on the new edition of the Healthcare Technology Report podcast with RJ Lumba. 
- [BioUtah Recognizes Nusano with Innovation Impact Award](https://nusano.com/bioutah-recognizes-nusano-with-innovation-impact-award/): SALT LAKE CITY – Nov. 5, 2025 – Nusano is honored to receive the 2025 Innovation Impact Award from BioUtah. The award recognizes organizations making an indelible mark on Utah's life sciences community.
- [Clarity signs copper-67 Supply Agreement with Nusano](https://nusano.com/clarity-signs-copper-67-supply-agreement-with-nusano/): The following is a copy of a press release issued by Clarity Pharmaceuticals
- [Nusano’s Lauren Radford Named “Healthcare Hero” by Utah Business](https://nusano.com/nusanos-lauren-radford-named-healthcare-hero-by-utah-business/): SALT LAKE CITY – October 14, 2025 – Nusano radiochemist Lauren Radford has been named a "Healthcare Hero" by Utah Business.
- [Nusano and Ariceum Therapeutics Announce Multi-Isotope Supply Agreement](https://nusano.com/nusano-and-ariceum-therapeutics-announce-multi-isotope-supply-agreement/): WEST VALLEY CITY, Utah and BERLIN, Germany – Oct. 14, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Ariceum Therapeutics (Ariceum), a targeted radiotherapeutics company dedicated to setting new standards in cancer care, today announced the signing of a multi-isotope supply agreement to support Ariceum’s novel radiotherapeutic pipeline.
- [Women Tech Council Names Melissa Daniels a Rising Star](https://nusano.com/women-tech-council-names-melissa-daniels-a-rising-star/): SALT LAKE CITY – Oct. 3, 2025 – Today, Nusano's Melissa Daniels was recognized as a “Rising Star” by the Women Tech Council at a luncheon in downtown Salt Lake City.
- [Nusano Ion Source Featured in Science Journal](https://nusano.com/nusano-ion-source-featured-in-science-journal/): Oct. 2, 2025 – The American Association for the Advancement of Science's Science journal has published an overview article of the radiopharmaceuticals industry and Nusano is featured prominently.
- [Nusano on Cover of Biosphere Magazine](https://nusano.com/nusano-on-cover-of-biosphere-magazine/): The breakthrough technologies of Nusano and the company's rapid growth in Utah are the cover story of the 2025 edition of Biosphere magazine. Published by BioUtah, Biosphere profiles the companies shaping Utah's life sciences economy. 
- [Nusano Announces September 2025 Conference Schedule](https://nusano.com/nusano-announces-september-2025-conference-schedule/): WEST VALLEY CITY, Utah – Sept. 4, 2025 – Nusano, a leader in advanced isotope and energy technologies, today announced its September conference schedule. Nusano CEO Chris Lowe will participate in panel discussions and company leadership will be available for one-on-one meetings. To request a meeting, contact info@nusano.com.
- [Photo Gallery: Production Facility Ribbon Cutting](https://nusano.com/photo-gallery-production-facility-ribbon-cutting/): On Thursday, August 21, 2025, Nusano cut the ribbon on the company's custom-built, 190,000-square-foot radioisotope production facility in West Valley City, Utah. Joining company officials for the event was Utah Governor Spencer Cox. 
- [Nusano in the News: Ribbon Cutting](https://nusano.com/nusano-in-the-news-ribbon-cutting/): Utah Gov. Spencer Cox stood alongside several leaders from Nusano...for the ribbon cutting of a new 190,000-square-foot radioisotope production facility in West Valley City.
- [Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility](https://nusano.com/nusano-cuts-ribbon-on-state-of-the-art-radioisotope-production-facility/): WEST VALLEY CITY, Utah – Aug. 21, 2025 – Nusano, a physics company transforming the production of radioisotopes, today cut the ribbon on its 190,000-square-foot radioisotope production facility. The site will be capable of producing more than 40 different radioisotopes for use in cancer diagnostics and therapeutics, as well as industrial applications, such as long-lived nuclear batteries.
- [Nusano Establishes Strategic Advisory Board to Support Innovation Across Company’s Product Verticals](https://nusano.com/nusano-establishes-strategic-advisory-board-to-support-innovation-across-companys-product-verticals/): WEST VALLEY CITY, Utah – Aug. 7, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the formation of a Strategic Advisory Board and the appointment of its first three members. The Board will provide guidance and insights as the company brings its breakthrough radioisotope production and mass separation technologies to rapidly evolving industrial, commercial, aerospace, and defense markets, including HALEU nuclear fuel production and radioisotope-powered nuclear batteries.
- [Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes](https://nusano.com/nusano-achieves-key-technology-milestone-enabling-simultaneous-production-of-multiple-radioisotopes/): WEST VALLEY CITY, Utah – July 9, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced it has received and successfully tested new equipment for its particle accelerator that will enable it to produce up to 12 different radioisotopes simultaneously. It has installed custom-built klystrons (high powered microwave vacuum tubes) and fast-pulse modulators, that together with custom-designed fast switching magnets, allow it to accelerate and steer its heavy ion particle beam. This is an important milestone and major differentiator for the Nusano platform. Other commercially available particle acceleration methods for radioisotope production are using low currents which support only limited isotope production.
- [Talk Radioisotopes: Paul Schrimpf, Proprietor & Entrepreneur, Cyrall](https://nusano.com/talk-radioisotopes-paul-schrimpf-proprietor-entrepreneur-cyrall/): With a background spanning Accenture, Prophet, and leadership roles advising top healthcare organizations, Paul draws on deep experience across strategy, marketing, and team development to lay out what radiopharma innovators can learn from the broader B2B and life sciences sectors. He explains why too many startups fall in love with their technology before identifying a buyer, and why clarity, not complexity, is the foundation of effective communication.
- [Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement](https://nusano.com/cellectar-biosciences-and-u-s-based-nusano-enter-into-multi-isotope-supply-agreement/): FLORHAM PARK, N.J. and WEST VALLEY CITY, Utah, June 26, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, and Nusano, a physics company transforming the production of radioisotopes, today announced the signing of a multi-year supply agreement in which Nusano will provide Cellectar with iodine-125 (I-125) and actinium-225 (Ac-225) for its clinical studies and future commercial needs.
- [Nusano CEO Chris Lowe on Connor Group Podcast](https://nusano.com/nusano-ceo-chris-lowe-on-connor-group-podcast/): Nusano's CEO, Chris Lowe, recently spoke to Ravi Kumar for the Connor Group's Breakthrough Work podcast.
- [dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply](https://nusano.com/dgenthera-and-nusano-sign-letter-of-intent-for-astatine%e2%80%91211-supply/):  DURHAM, N.C. and WEST VALLEY CITY, Utah – June 19, 2025 – dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a physics company transforming the production of radioisotopes, today announced the signing of a letter of intent to provide dGenThera with access to high‑purity astatine‑211 (At‑211), a best‑in‑class alpha‑emitting isotope for cancer therapy.
- [Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmaceuticals](https://nusano.com/supply-agreement/): BOSTON and WEST VALLEY CITY, Utah – June 17, 2025 – Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, and Nusano, a physics company enabling breakthrough radioisotope supplies, today announced a long-term supply agreement designed to support the Ratio’s product pipeline and enable innovation.
- [Nusano Announces Breakthrough HALEU Program Expected to Produce Up to 350 Metric Tons of Fuel Annually for Advanced Nuclear Reactors](https://nusano.com/nusano-announces-breakthrough-haleu-program-expected-to-produce-up-to-350-metric-tons-of-fuel-annually-for-advanced-nuclear-reactors/): WEST VALLEY CITY, Utah – June 11, 2025 – Nusano, a physics company transforming radioisotope production and enabling next-generation energy solutions, announced today the launch of a High-Assay Low-Enriched Uranium (HALEU) production program to support the need for new, sustainable energy solutions and small modular nuclear reactor (SMR) infrastructure in the United States.
- [Nusano Stable Isotope Program Enriches Gadolinium-160 to 99.2% Purity](https://nusano.com/nusano-stable-isotope-program-enriches-gadolinium-160-to-99-2-purity/): WEST VALLEY CITY, Utah – June 10, 2025 – Nusano today announced it has successfully enriched gadolinium-160 (Gd-160) to 99.2% purity, a significant milestone demonstrating the company’s in-house stable isotope production program.
- [VIP Preview Tour Draws a Crowd](https://nusano.com/vip-preview-tour-draws-a-crowd/): By Jessica Budin
- [Talk Radioisotopes: Sigal Kalmanson Cusnir, CEO and Co-Founder, Starget Pharma](https://nusano.com/talk-radioisotopes-sigal-kalmanson-cusnir/): In this episode of Talk Radioisotopes, host Scott Larrivee sits down with Sigal Kalmanson, CEO and Co-Founder of Starget Pharma, an early-stage company at the forefront of precision oncology. Starget is redefining the way radiopharmaceuticals are discovered and developed by merging AI technology with decades of expertise in peptide chemistry.
- [Talk Radioisotopes: Milton Lönnroth, Co-Founder and CEO, Atley Solutions](https://nusano.com/talk-radioisotopes-milton-lonnroth-co-founder-and-ceo-atley-solutions/): In this episode, Milton Lönnroth, Co-Founder and CEO, shares how Atley Solutions is changing the game for astatine-211, a promising isotope in cancer therapy. Atley supports radiopharmaceutical companies and researchers by enabling the scalable production and labeling of astatine-based compounds. Milton explains how the company's roots in the University of Gothenburg’s alpha therapy group shaped a mission focused squarely on patient needs, especially for challenging cancers like metastatic ovarian cancer. The company's first commercial product, the C100 module, automates the purification, labeling, and preparation of astatine-211 drug products, significantly lowering the barrier to entry for researchers and clinical developers alike.
- [Registration for 2025 World Astatine Community Meeting Now Open](https://nusano.com/registration-for-2025-world-astatine-community-meeting-now-open/): Radiopharmaceutical experts and researchers to gather June 19-20 in New Orleans
- [Nusano to Participate in Radiopharma Supply Chain Panel at the 21st Annual PEGS Summit Boston](https://nusano.com/nusano-to-participate-in-radiopharma-supply-chain-panel-at-the-21st-annual-pegs-summit-boston/): WEST VALLEY CITY, Utah – May 12, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced its Chief Product Officer, Kevin Haehl, will participate in a radioisotope supply chain panel discussion at the 21st Annual PEGS (Protein & Antibody Engineering) Summit on Wednesday, May 14, 2025, in Boston.
- [Talk Radioisotopes: Dr. Luke Nordquist, Founder & CEO of XCancer](https://nusano.com/talk-radioisotopes-dr-luke-nordquist-founder-ceo-of-xcancer/): In this episode, host Scott Larrivee speaks with Dr. Luke Nordquist, a medical oncologist and Founder/CEO of XCancer, a globally recognized clinical research center. Dr. Nordquist shares the origin story of XCancer—born out of a desire to bring cutting-edge prostate cancer trials to community care settings—and how it has grown into a nationwide clinical research network supporting over 45 community cancer centers. With a patient-first philosophy, Luke discusses building operational efficiency, launching world-first trials, and developing proprietary research software to streamline clinical operations.
- [Nusano Names Rachel Culbertson VP of Supply Chain](https://nusano.com/nusano-names-rachel-culbertson-vp-of-supply-chain/): WEST VALLEY CITY, Utah – April 30, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the appointment of Rachel Culbertson as Vice President of Supply Chain. Culbertson’s leadership will be instrumental as Nusano scales to meet growing demand across medical, aerospace, and energy markets, with its diversified portfolio of over 40 radioisotopes. Culbertson and her team will oversee sourcing, internal operations and implementation of best practices to support reliable, high-volume production.
- [Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano](https://nusano.com/clarity-signs-high-volume-commercial-scale-copper-64-supply-agreement-with-nusano/): The following is a copy of a press release issued by Clarity Pharmaceuticals on April 17, 2025 in Australia. Minor edits have been made in this copy to account for English spelling preferences in the United States.
- [Talk Radioisotopes: Matt Furlow, Associate Principal & Head of the ZS Radiopharmaceutical Center of Excellence](https://nusano.com/talk-radioisotopes-matt-furlow-associate-principal-head-of-the-zs-radiopharmaceutical-center-of-excellence/): On this episode, hosts Scott Larrivee and Sarah Scouten are joined by Matt Furlow, Associate Principal & Head of the Radiopharmaceutical Center of Excellence at ZS, about the evolving role of radiopharmaceuticals in oncology.
- [Nusano CEO Chris Lowe on A Dose of Reality Podcast](https://nusano.com/nusano-ceo-chris-lowe-on-dose-of-reality-podcast/): Nusano CEO Chris Lowe appears on the A Dose of Reality podcast hosted by Charles Spence.

## Pages
- [Media Kit](https://nusano.com/news/nusano-media-kit/): Nusano offers a media kit to members of the press. It features downloadable company logos, images and video.
- [Now Hiring](https://nusano.com/careers/now-hiring/): Now Hiring: Check out our open positions below and apply directly from this page. We can't wait to meet you!
- [Astatine-211: Product Page](https://nusano.com/life-sciences/products-medical-radioisotopes/astatine-211/): Astatine-211 is a radioactive isotope of the element astatine, which has the atomic number 85. It is notable for its relatively short half-life of about 7.2 hours and emits alpha particles during its decay process. The main use of astatine-211 is in targeted alpha-particle therapy for cancer treatment. Its alpha emissions can destroy cancer cells with minimal damage to surrounding healthy tissue, making it suitable for use in radiopharmaceuticals that selectively target tumors. Researchers are investigating astatine-211 for its potential in treating various cancers, including leukemia, lymphoma, and certain solid tumors.
- [Contact Sales](https://nusano.com/company/contact-us/contact-sales/): "Working at Nusano means being a part of something bigger. Our isotopes are a critical part of the solution to global supply challenges in nuclear medicine, and I get to help customers navigate that every day."
- [Careers Email Sign Up](https://nusano.com/careers/nusano-careers-email-sign-up/): CAREERS INFORMATION
- [Nu-Blog](https://nusano.com/news/nu-blog/): Jun 26, 2026
- [Strategic Advisory Board](https://nusano.com/company/strategic-advisory-board/): Nusano's Strategic Advisory Board provides insights and  guidance supporting the company's commercialization of breakthrough radioisotope production and mass separation technologies for rapidly evolving industrial, commercial, aerospace, and defense markets, including HALEU nuclear fuel production and radioisotope-powered nuclear batteries.
- [Email Sign Up](https://nusano.com/news/email-sign-up/): Be among the first to receive Nusano news and updates by joining our mailing list.
- [Nuclear Fuel Cycle](https://nusano.com/clean-energy/nuclear-fuel-cycle-solutions/): One of the biggest objections to nuclear power is the danger and multi-generational storage needs of spent fuel rods removed from reactors.
- [HALEU](https://nusano.com/clean-energy/haleu/): Nusano has launched a High-Assay Low-Enriched Uranium (HALEU) production program to support the need for new, sustainable energy solutions and small modular nuclear reactor (SMR) infrastructure in the United States.
- [ACCESS REPLAY: 2025 Radiopharma Preview](https://nusano.com/news/video/access-replay-2025-radiopharma-preview/): Join industry experts, Elcin Zan, MD (Cleveland Clinic) and Brian Zeglis, PhD (Hunter College), for a look-forward discussion of emerging trends and exciting developments poised to shape radiopharmaceuticals in 2025.
- [Industrial](https://nusano.com/industrial/): Enabling MOdern Operations
- [Technology](https://nusano.com/technology/): Nusano's core technology is poised to support advancements across multiple industries, ranging from oncology to clean energy.
- [Energy](https://nusano.com/clean-energy/): Nusano has developed a proprietary ion source capable of generating neutrons on a scale far greater than current particle accelerator technologies. When applied to the problem of nuclear waste, this technology can dramatically shorten the radioactive half-life of spent nuclear fuel and other byproducts – all while simultaneously   generating clean energy for the system’s operation and the electrical grid.
- [Nuclear Batteries](https://nusano.com/clean-energy/nuclear-batteries/): Nuclear batteries offer dependable power for everything from ground-based remote sensors to satellites in space.
- [Medical Radioisotopes Advisory Board](https://nusano.com/company/medical-radioisotopes-advisory-board/): The Nusano Medical Radioisotopes Advisory Board works to keep the company apprised of emerging industry trends, guide the development of isotopes for next-generation theranostic compounds, and identify ways to better serve cancer patients. We are honored to have these leaders in healthcare and industry providing their input as Nusano works to supply the fight against cancer by making medical radioisotopes available and abundant.
- [Talk Radioisotopes Podcast](https://nusano.com/news/talk-radioisotopes-podcast/): Whether you’re a healthcare professional, researcher, pharma exec, or industry analyst, this podcast is a go-to resource for the rapidly evolving radiopharmaceuticals landscape.
- [Life Sciences](https://nusano.com/life-sciences/): Nusano’s role in the life sciences and health care ecosystem is as a supplier of medical radioisotopes to drugmakers, hospitals and clinics. With a reliable supply of radioisotopes, these teams can then formulate treatments and next-generation pharmaceuticals needed to advance the fight against cancer.
- [Video](https://nusano.com/news/video/): Recorded December 17, 2024
- [HOWARD C. LEWIN](https://nusano.com/company/howard-c-lewin/): CO-FOUNDER & CHIEF PRODUCT DEVELOPMENT OFFICER
- [GLENN B. ROSENTHAL](https://nusano.com/company/glenn-b-rosenthal/): CHIEF TECHNOLOGY OFFICER
- [Mission & Values](https://nusano.com/careers/mission-vision-values/): Nusano is transforming the future with breakthrough physics and radioisotope production enabling advancements in the life sciences and beyond. Our work empowers researchers, innovators and governments to pioneer life-changing breakthroughs, transform modern operations, and solve some of humanity’s most pressing challenges.
- [R&D Collaboration](https://nusano.com/life-sciences/rd-collaboration/): Nusano's expert teams and facilities help our collaborators develop their ideas, test new solutions, and accelerate drug development.
- [About Nuclear Medicine](https://nusano.com/life-sciences/about-nuclear-medicine/): From finding disease to treating it, nuclear medicine is widely practiced throughout modern healthcare
- [Products by Emission](https://nusano.com/life-sciences/products-medical-radioisotopes/products-by-emission/): Nusano's production platform enables the creation of rare and hard-to-produce medical radioisotopes in quantities needed for commercial-stage diagnostics and therapeutics.
- [Medical Isotopes](https://nusano.com/life-sciences/products-medical-radioisotopes/): Nusano is now accepting orders for near-term and future production. Don't miss out! Request your custom quote today.
- [Life in Utah](https://nusano.com/careers/life-in-utah/): Utah was ranked the #1 state in the nation by U.S. News and World Report. Learn more about what it's like to live in Salt Lake City and discover all the cultural and entertainment opportunities the state has to offer.
- [Careers](https://nusano.com/careers/): Joining Nusano is a chance to do once‑in‑a‑lifetime work. Our teams are working to make medical radioisotopes available and abundant to support next-generation cancer therapeutics.
- [Contact Us](https://nusano.com/company/contact-us/): Thank you for your interest in Nusano. Please complete the form below and the appropriate member of our team will follow up with you.
- [West Valley City](https://nusano.com/company/utah/): West Valley City, Utah 
- [News](https://nusano.com/news/): News, Awards & Honors, Utah
- [Company](https://nusano.com/company/): Nusano's breakthrough technologies are creating radioisotope solutions for healthcare, industry and modern life
- [Home](https://nusano.com/): Nusano is committed to bringing stability and innovation to the rapidly emerging and critically undersupplied medical radioisotopes market.